10202017Headline:

Contrast Injector Market is projected to reach USD 636.1 million by 2021 from USD

May 31, 2017 - (Newswire)

-

Highlights

  • The contrast injector market is projected to reach USD 636.1 million by 2021 from USD 445.5 million in 2016.
  • The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers.
  • The global contrast injector market is segmented on the basis of product, application, and region.
  • In 2016, North America is expected to account for the largest share of the global contrast injector market, followed by Europe, Asia-Pacific, and the Rest of the World
  • Asia-Pacific is projected to have the highest growth rate in the forecast period.
  • The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings.

The contrast injector market is projected to reach USD 636.1 million by 2021 from USD 445.5 million in 2016, growing at a CAGR of 7.4% in the next five years (2016 to 2021). The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent.

The global contrast injector market is segmented on the basis of product, application, and region. In 2016, North America is expected to account for the largest share of the global contrast injector market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. The high growth rate of this segment can be attributed to factors such as rising aging population and cancer incidences, expansion of international players in China and India, increasing R&D investments in China, and favorable regulatory changes in New Zealand and Australia.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (market developments (product approvals); product deployment; product launch; and other strategies (grants, award & recognition, investment, expansion, agreements, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the contrast injector market.

- By Company Type: Tier 1: 10%, Tier 2: 63%, Tier 3: 27%
- By Designation: Director Level: 19%, C-level: 28%, Others: 53%
- By Region: North America: 27%, Europe: 27%, APAC: 30%, RoW: 16%

Key players in the global contrast injector market include Bracco Imaging S.p.A (Italy), Bayer HealthCare (Germany), Guerbet Group (France), GE Healthcare (U.S.), ulrich GmbH & Co. KG, (Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), Apollo RT Co., Ltd. (China), VIVID IMAGING (China), and AngioDynamics(U.S.)

Research Coverage:
The report provides a picture of the contrast injector market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the products and services offered by top players in the contrast injector market. The report analyzes the contrast media injector by product, application, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the contrast injector market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for contrast injectors across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the contrast injector market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the contrast injector market.

Read the full report: www.reportlinker.com/p04901890/Contrast-Injector-Market-by-Product-Consumables-Accessories-Application-Global-Forecast-to.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

www.reportlinker.com

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

www.reportlinker.com

Original Source: https://www.newswire.com/news/contrast-injector-market-is-projected-to-reach-usd-636-1-million-by-2021-from

What Next?

Related Articles

Leave a Reply

Submit Comment